Severe Hyponatremia in the ED: Bolus for Symptoms, Brake for Risk
Chester "Chet" Shermer, MD, FACEP · November 5, 2026
About the author: Dr. Chester Shermer, MD, FACEP
When 3% saline goes in now, how much to give, the 24-hour ceilings that still stand, and why the kidney often drives overcorrection.
A 74-year-old retiree who lives alone arrives with her daughter after two days of vomiting. Her primary care doctor started hydrochlorothiazide six weeks ago. She is slow to answer in triage, and ten minutes later she has a generalized seizure on the stretcher. The blood gas sodium is 111 mmol/L.
She needs hypertonic saline now, with a goal of about 5 mmol/L in the first hour. After that, the work changes direction: for the next 24 hours, your job is to stop her sodium from rising too far, and her history holds two of the classic reasons it overshoots.
Symptoms decide who gets the bolus
The guidelines tie the decision to the patient's neurologic state, and the sodium value comes second. The 2014 European guideline calls vomiting, cardiorespiratory distress, abnormal and deep somnolence, seizures and coma (GCS 8 or less) severe symptoms [1]. Nausea without vomiting, confusion and headache are moderately severe [1]. Severe symptoms get hypertonic saline immediately, whatever the cause [3].
The two dosing schemes in common use are close:
- European guideline (2014): 150 mL of 3% saline IV over 20 minutes, check the sodium, and repeat up to twice until the sodium has risen 5 mmol/L [1].
- US expert panel (2013): 100 mL of 3% saline IV over 10 minutes, up to three doses in total, for severe neurologic symptoms [2].
Both are fixed volumes. Neither asks you to calculate a deficit at the bedside. That matters, because formulas do poorly here: in one teaching-hospital review of 62 patients treated with 3% saline, the observed rise exceeded the Adrogué-Madias prediction in 74% of patients whose starting sodium was below 120, and the overcorrectors rose by 2.4 times the predicted amount [12].
A randomized trial compared intermittent boluses with a slow infusion. It used weight-based doses (2 mL/kg of 3% saline per bolus), so it tested the bolus method and not the 150 mL or 100 mL schemes [4]. SALSA enrolled 178 adults with symptomatic hyponatremia and glucose-corrected sodium of 125 mmol/L or less in emergency departments and wards at three Korean hospitals [4]. Rapid intermittent boluses and a slow continuous infusion produced similar overcorrection: 17.2% versus 24.2%, a difference that was not significant [4]. SALSA defined overcorrection as more than 12 mmol/L in 24 hours or 18 in 48, a looser line than the European 10 [1][4]. The bolus arm needed fewer relowering treatments (41.4% versus 57.1%) and reached the one-hour target more often in the intention-to-treat analysis (32.2% versus 17.6%) [4].
If the seizure continues, run your status epilepticus sequence at the same time. The saline treats the cause.
Correction limits are ceilings
Once the dangerous symptoms ease, the target changes from speed to restraint. The European guideline limits the rise to 10 mmol/L in the first 24 hours and 8 mmol/L in each 24 hours after that [1]. A 2026 review in Clinical Kidney Journal keeps the same structure for average-risk patients: no more than 10 mmol/L in 24 hours or 18 in 48, aiming for 4 to 8 per day [5]. For patients at high risk of osmotic demyelination, the US panel and that review set the ceiling at 8 mmol/L in 24 hours, aiming for 4 to 6 [2][5].
High risk is a list you will recognize from any ED shift. In a 3,274-patient multicenter cohort of admission sodium below 120, six of the seven patients who developed central pontine myelinolysis had alcohol use disorder, malnutrition, hypokalemia or hypophosphatemia, and five of the seven had corrected at 8 mmol/L per 24 hours or less [6]. In a single-center German ED cohort of 852 patients with sodium of 125 or less, alcoholism, liver disease and malnutrition were the risk factors for demyelination [7].
These numbers are maximums, and the daily targets in that review sit well below them [5]. Once the seizure has stopped, the rest of the first day is about holding the gain.
The mortality debate, read carefully
A real argument is underway about whether those limits are too tight. The 2023 NEJM Evidence cohort found that correction slower than 6 mmol/L per 24 hours was associated with higher in-hospital mortality than 6 to 10, and that correction faster than 10 was associated with lower mortality and shorter stays [6]. A 2025 JAMA Internal Medicine meta-analysis of 16 cohort studies (11,811 patients) reported 32 fewer in-hospital deaths per 1,000 with rapid versus slow correction (OR 0.67, moderate certainty) and no statistically significant increase in demyelination [8].
Every study in that column is observational. The other column is observational too, and it points the other way on demyelination. A 2025 meta-analysis of 11 cohorts (26,710 patients) found demyelination in 0.73% after rapid correction and 0.10% after slower correction (OR 3.16) [9]. A 2026 Emergency Medicine Journal meta-analysis found lower mortality with rapid correction at every threshold it tested, an overall demyelination rate of 0.085%, and higher odds of demyelination with rapid correction (OR 3.96) [10]. In the ED cohort above, cerebral edema was found in 0.5% and demyelination in 1.3% [7]. Overly rapid correction (more than 8 mmol/L at 24 hours) showed no link to demyelination in the full group, but it became the main risk factor in a smaller subset with more accurate 24-hour sodium values; correction rate did not affect mortality or length of stay, and the authors concluded the limits should stay [7].
A 2024 review by authors from 20 centers in nine countries urged clinicians to keep the safeguards until better evidence exists [11], and the 2026 review reached the same conclusion [5]. None of the mortality data comes from a randomized comparison of ceilings. Until better evidence arrives, the published 24-hour limits remain the standard.
The kidney drives much of the overshoot
In the 62-patient review, documented water diuresis caused 40% of inadvertent overcorrections, and the authors named unrecognized hypovolemia and other reversible causes of water retention as the danger [12]. The patient in the opening scene has two of them. Stop the thiazide and restore her volume, and her vasopressin falls; she can then excrete large volumes of dilute urine and raise her own sodium quickly.
So measure urine output from the start, recheck sodium often, and decide early what the brake will be. If a limit is exceeded, stop hypertonic fluid and bring in a clinician experienced in managing overcorrection, who can decide on hypotonic fluid, with or without desmopressin to stop the water loss [3]. Some centers give desmopressin before the rise starts. A 2026 meta-analysis of six studies (1,881 patients, 168 given proactive desmopressin) found lower odds of overcorrection (OR 0.29) but no difference in demyelination, mortality or length of stay [13]. That plan belongs to the team that will run it overnight, and it should be in the handoff by name.
Key Takeaways
- Treat severe symptoms at once: 150 mL of 3% saline over 20 minutes (or 100 mL over 10), rechecked and repeated up to a total of three doses, aiming for about 5 mmol/L in the first hour [1][2].
- Write the ceiling as a number in the chart: no more than 10 mmol/L in the first 24 hours for most patients [1][5], and 8 for anyone with a starting sodium of 105 or less, alcohol use disorder, malnutrition, advanced liver disease or hypokalemia [2][5].
- Expect the overshoot after you fix the cause: volume repletion and stopping a thiazide release a water diuresis, the cause of 40% of overcorrections in one series [12].
- Read the faster-correction data as a signal, not a license: the mortality benefit is observational, demyelination still tracks with rapid correction, and current guidance keeps the limits [5][9][11].
FAQ
What symptoms count as severe hyponatremia?
The European guideline lists vomiting, cardiorespiratory distress, abnormal and deep somnolence, seizures, and coma with a GCS of 8 or less [1]. Nausea without vomiting, confusion and headache are moderately severe [1]. Severe symptoms are unlikely when the sodium is above 130 mmol/L, so look for another cause of the neurologic change in that patient [3].
What is the maximum sodium correction in 24 hours?
The European guideline sets 10 mmol/L in the first 24 hours and 8 mmol/L in each 24 hours after that [1]. The US panel defines high risk as a sodium of 105 mmol/L or less, hypokalemia, alcoholism, malnutrition or advanced liver disease, and sets a ceiling of 8 mmol/L in 24 hours for those patients [2][5]. These are limits, so plan to stay well under them once symptoms resolve.
Does faster sodium correction lower mortality?
Observational studies and a 2025 meta-analysis associate faster correction with lower in-hospital mortality [6][8]. Every one of those studies is observational, and demyelination remains more common after rapid correction in pooled data [9][10]. Current expert reviews recommend keeping the existing limits until higher-quality evidence is available [5][11].
Dr. Chet's Take
I have worked as an emergency physician for more than 25 years at a Level I academic trauma center, and I am also a HEMS medical director, so I meet this disorder both at the bedside and on interfacility transfers. The article holds up. Its most useful move is to treat the first hour and the next twenty-four as two separate problems with two separate risks. The bolus is the short, loud part of the case, and the seizing patient tells you quickly whether it worked. The quiet part comes later, when she is awake, talking to her daughter, and everyone in the room relaxes. That is the stretch where overcorrection happens. I would rather defend a sodium that rose 6 points than explain one that rose 14 overnight.
That being said, I think the article understates where the plan breaks: at the seams between teams. The ED gives the bolus, and someone else owns the next twenty hours. Every handover is a chance for the sodium draw interval to stretch without anyone choosing that. In a small hospital on a telemedicine link, the lab may be slower overnight, and an interfacility transfer adds hours in which nobody can check a level at all. The honest answer is that I do not know how much overcorrection starts in those gaps, because I have not seen it measured. I do know that a ceiling with no named owner is a wish. Assign the next sodium check to a person before you assign the bed.
If you are the attending, write three numbers in your note: the starting sodium, the 24-hour ceiling as an absolute value, and the time of the next draw. Order strict urine output with the first bolus. If the patient is leaving by ground or by air, send the sodium trend and the ceiling with the crew, and tell the receiving physician whether the cause has already been removed, because that decides how fast the next rise comes. Ask the admitting team which brake they will use if the sodium runs: hypotonic fluid, desmopressin, or both, and who will order it at 0300. If you are the physician receiving the patient, read the ceiling before you write the first fluid order. The 24-hour ceiling is part of the treatment, and it belongs in the order set next to the bolus.
— Chester Shermer, MD, FACEP | Emergency Medicine, 25+ Years Clinical Experience | State Surgeon
Continue Your Training
If you're an emergency physician (or any clinician treating patients daily) trying to understand how AI will actually impact your clinical practice — not just the hype — I put together a free practical guide. You can download the AI in EM Survival Guide here.
Browse All Courses at Global MedOps Command
Relevant Reading on Global MedOps Command:
How to Avoid Becoming an AI Casualty — Dr. Shermer's guide to navigating AI tools in clinical and operational settings without compromising judgment or patient outcomes.
Emergency Department Efficiency Playbook — Practical systems for throughput, triage optimization, and operational efficiency.
Read more from Dr. Shermer on Medium
Connect with Dr. Shermer: LinkedIn — Chester "Chet" Shermer, MD, FACEP.
References
- Spasovski G, Vanholder R, Allolio B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol. 2014;170(3):G1-G47. PubMed 24569125
- Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med. 2013;126(10 Suppl 1):S1-S42. PubMed 24074529
- Ball S, Barth J, Levy M, et al. Society for Endocrinology endocrine emergency guidance: emergency management of severe symptomatic hyponatraemia in adult patients. Endocr Connect. 2016;5(5):G4-G6. PubMed 27935814
- Baek SH, Jo YH, Ahn S, et al. Risk of overcorrection in rapid intermittent bolus vs slow continuous infusion therapies of hypertonic saline for patients with symptomatic hyponatremia: the SALSA randomized clinical trial. JAMA Intern Med. 2021;181(1):81-92. PubMed 33104189
- Kamel KS, Harel Z, Schreiber M. Managing hyponatremia: fast or slow? Why, when, how, and controversies. Clin Kidney J. 2026;19(10):sfag288. PubMed 42824684
- Seethapathy H, Zhao S, Ouyang T, et al. Severe hyponatremia correction, mortality, and central pontine myelinolysis. NEJM Evid. 2023;2(10):EVIDoa2300107. PubMed 38320180
- Burst V, Rabii R, Peto-Madew J, et al. Severe hyponatremia in the emergency department: incidence of cerebral edema and risk of osmotic demyelination syndrome. Acad Emerg Med. 2026;33(1):e70158. PubMed 41069084
- Ayus JC, Moritz ML, Fuentes NA, et al. Correction rates and clinical outcomes in hospitalized adults with severe hyponatremia: a systematic review and meta-analysis. JAMA Intern Med. 2025;185(1):38-51. PubMed 39556338
- Suppadungsuk S, Krisanapan P, Kazeminia S, et al. Hyponatremia correction and osmotic demyelination syndrome risk: a systematic review and meta-analysis. Kidney Med. 2025;7(3):100953. PubMed 39967825
- Matrisch L, Rau Y, Graßhoff L, et al. On the optimal sodium correction rate in hyponatraemia and clinical outcome: a meta-analysis. Emerg Med J. 2026;43(10):647-654. PubMed 42097878
- Sterns RH, Rondon-Berrios H, Adrogué HJ, et al. Treatment guidelines for hyponatremia: stay the course. Clin J Am Soc Nephrol. 2024;19(1):129-135. PubMed 37379081
- Mohmand HK, Issa D, Ahmad Z, et al. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. Clin J Am Soc Nephrol. 2007;2(6):1110-1117. PubMed 17913972
- Lins PRG, Uvinha F, Passos FS, et al. Proactive desmopressin for the prevention of serum sodium overcorrection in moderate-to-severe hyponatremia: a systematic review and meta-analysis. BMC Nephrol. 2026;27:494. PubMed 42351030
Related simulation training: Books by Dr. Shermer